Income StatementBalance SheetCash FlowSegments
Idexx Laboratories logo

Idexx Laboratories Cash Flow Statement

Operating, investing, and financing cash movements

Idexx Laboratories generated $1.2B in operating cash flow over the trailing twelve months. After $126.6M in capital expenditures, free cash flow was $1.1B. Free cash flow increased 0.3% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$1.2BNet Cash From Investing (TTM)-$140.2MNet Cash From Financing (TTM)-$1.0BCapital Expenditures (TTM)$126.6MDepreciation And Amortization Cf (TTM)$148.8MNet Change In Cash (TTM)$36.6M
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$41.7B
P/E Ratio38.08
ROE72.92%

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures incurred but not yet paid—$10.7M-$2.2M-$1.7M—$8.3M
Capital expenditures incurred but not yet paid—$10.7M-$2.2M-$1.7M—$8.3M
Capital Expenditures Incurred but Not Yet Paid—$10.7M-$2.2M-$1.7M—$8.3M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from lines of credit$0.0$69.5M$259.5M-$124.0M—$132.0M
Proceeds from exercises of stock options and other stock issuances$13.3M$7.2M$17.3M$51.0M$17.9M$18.2M
Proceeds from Secured Long-Term Debt$0.0$62.5M$62.5M$62.5M$62.5M—
Repayments of Secured Debt$0.0$62.5M$62.5M$62.5M$62.5M—
Net cash from financing activities-$232.8M-$330.3M-$165.6M-$313.3M-$355.7M-$211.4M
Repurchases of common stock$246.0M$400.9M$338.1M$240.2M$237.8M$351.0M
Taxes paid for net share settlement$45.0K$6.1M$970.0K$85.0K$60.0K$10.6M
Proceeds from Issuance of Secured Debt$0.0$62.5M$62.5M$62.5M$62.5M—

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$29.3M$30.0M$34.1M$31.1M$29.4M$32.0M
Payments to Acquire Equity Securities, FV-NI$251.0K$0.0———$799.0K
Payments to Acquire Intangible Assets$2.5M$0.0———$1.8M
Net cash from investing activities-$39.8M-$29.6M-$33.6M-$44.9M-$28.1M-$33.5M
Derivative Collateral and Settlements (Investing)$416.0K$416.0K$474.0K$349.0K$1.5M$1.0M
Proceeds from Hedge Investing Activities$416.0K$416.0K$474.0K$349.0K$1.5M$1.0M
Payments for Deposits$2.5M$0.0———$1.8M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable$5.7M-$8.1M-$4.0M$7.1M-$3.6M$11.2M
Change in accounts receivable—$45.2M$29.6M$7.7M—$56.8M
Change in inventories$3.2M-$2.2M$6.2M-$1.9M—-$2.2M
Other working capital changes$434.0K$456.0K$1.0M$1.8M$1.8M$695.0K
Deferred income taxes—$3.9M$2.5M$93.2M$31.5M$13.9M
Depreciation and amortization$33.7M$34.1M$35.8M$36.6M$38.7M$37.7M
Net cash from operating activities$262.0M$238.0M$185.7M$402.3M$355.8M$266.2M
Net income$216.1M$242.7M$294.0M$274.6M$248.2M$278.4M
Asset write-downs$0.0$0.0$0.0$0.0—$5.0M
Provision for Loan, Lease, and Other Losses$1.8M$2.9M$1.5M$1.6M$2.5M$3.9M
Stock-based compensation$14.3M$14.6M$14.9M$14.4M$16.1M$16.3M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$232.8M$207.9M$151.6M$371.2M$326.3M$234.3M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$9.8M-$2.3M$14.1M-$587.0K$0.0-$816.0K
Net increase (decrease) in cash-$20.4M-$124.3M$624.0K$43.6M-$28.1M$20.5M
Accrued payables for capital expenditures—$10.7M-$2.2M-$1.7M—$8.3M